Predictions
Cellectis SA ADR
Start price
Target price
Perf. (%)
€6.75
11.01.22
11.01.22
€8.00
11.01.23
11.01.23
-65.63%
07.10.22
07.10.22
Could be worthwhile Investment >10% per year
Avenue Therapeutics Inc.
Start price
Target price
Perf. (%)
€14.38
03.10.22
03.10.22
€7.00
03.10.23
03.10.23
-44.51%
06.10.22
06.10.22
Good culture
Probably not worthwhile Investment
Below average Management
No Innovation
Avenue Therapeutics Inc.
Start price
Target price
Perf. (%)
€10.76
30.09.22
30.09.22
-
30.09.23
30.09.23
39.41%
03.10.22
03.10.22
Risky Investment
Inovio Pharma
Start price
Target price
Perf. (%)
€1.88
20.09.22
20.09.22
€1.60
20.09.23
20.09.23
-7.46%
03.10.22
03.10.22
Very low/no dividend yield expected
Risky balance sheet
ROE lower than 10% per year
Increased challenges to pay loans and raise capital
Omeros Corp.
Start price
Target price
Perf. (%)
€7.20
02.10.21
02.10.21
-
02.10.22
02.10.22
-53.29%
03.10.22
03.10.22
Probably not worthwhile Investment
Adaptimmune Therapeutics PLC ADR
Start price
Target price
Perf. (%)
€1.16
27.09.22
27.09.22
-
27.09.23
27.09.23
-4.31%
01.10.22
01.10.22
Risky Investment
Intercept Pharmaceuticals
Start price
Target price
Perf. (%)
€17.43
18.09.22
18.09.22
-
18.09.23
18.09.23
-17.30%
01.10.22
01.10.22
Risky Investment
Avenue Therapeutics Inc.
Start price
Target price
Perf. (%)
€8.29
27.09.22
27.09.22
-
27.09.23
27.09.23
26.64%
01.10.22
01.10.22
Risky Investment
Intercept Pharmaceuticals
Start price
Target price
Perf. (%)
€15.08
21.09.22
21.09.22
-
21.09.23
21.09.23
-4.44%
01.10.22
01.10.22
Risky Investment
Prothena Corp. plc
Start price
Target price
Perf. (%)
€54.86
28.09.22
28.09.22
-
28.09.23
28.09.23
12.14%
01.10.22
01.10.22
Risky Investment
Forte Biosciences Inc.
Start price
Target price
Perf. (%)
€1.21
19.09.22
19.09.22
-
19.09.23
19.09.23
-12.19%
01.10.22
01.10.22
Capable Management
Could be very worthwhile Investment >20% year
Few uniques
Biogen Inc.
Start price
Target price
Perf. (%)
€199.36
07.09.22
07.09.22
€300.00
31.12.24
31.12.24
36.69%
30.09.22
30.09.22
Could be very worthwhile Investment >20% year
Biogen Inc.
Start price
Target price
Perf. (%)
€199.36
07.09.22
07.09.22
€300.00
31.12.24
31.12.24
36.69%
30.09.22
30.09.22
Could be very worthwhile Investment >20% year
Biogen Inc.
Start price
Target price
Perf. (%)
€199.36
07.09.22
07.09.22
€300.00
31.12.24
31.12.24
36.69%
30.09.22
30.09.22
Could be very worthwhile Investment >20% year
Intercept Pharmaceuticals
Start price
Target price
Perf. (%)
€16.65
20.09.22
20.09.22
€32.00
31.01.23
31.01.23
-17.72%
30.09.22
30.09.22
Could be very worthwhile Investment >20% year
Nicox S.A.
Start price
Target price
Perf. (%)
€3.19
29.09.21
29.09.21
€3.80
29.09.22
29.09.22
-46.37%
30.09.22
30.09.22
Could be worthwhile Investment >10% per year
Apellis Pharmaceuticals
Start price
Target price
Perf. (%)
€64.19
07.09.22
07.09.22
€35.00
31.12.24
31.12.24
8.24%
29.09.22
29.09.22
Could be very worthwhile Investment >20% year
Genfit S.A.
Start price
Target price
Perf. (%)
€3.36
26.09.21
26.09.21
-
26.09.22
26.09.22
14.15%
27.09.22
27.09.22
Could be worthwhile Investment >10% per year
Lysogene SA
Start price
Target price
Perf. (%)
€2.29
24.09.21
24.09.21
€3.00
24.09.22
24.09.22
-73.87%
25.09.22
25.09.22
Could be worthwhile Investment >10% per year
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€213.80
18.01.22
18.01.22
€350.00
18.01.23
18.01.23
47.33%
23.09.22
23.09.22
Top 10 in its market
Could be worthwhile Investment >10% per year
High dividend yield expected
Innovative
Arbutus Biopharma Corp.
Start price
Target price
Perf. (%)
€2.39
03.08.22
03.08.22
€2.80
03.08.23
03.08.23
-14.19%
20.09.22
20.09.22
Differentiated customer and product portfolio
Lower EBIT Margin than peer group
High valuation
Very low/no dividend yield expected
Inovio Pharma
Start price
Target price
Perf. (%)
€2.12
03.08.22
03.08.22
€2.60
03.08.23
03.08.23
-11.19%
20.09.22
20.09.22
Very low/no dividend yield expected
Risky balance sheet
ROE lower than 10% per year
Increased challenges to pay loans and raise capital